Ubs Group Ag Regeneron Pharmaceuticals, Inc. Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 71,500 shares of REGN stock, worth $52.9 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

71,500

Previous 254,461 71.9%

Holding current value

$52.9 Million

Previous $267 Million 71.9%

% of portfolio

0.02%

Previous 0.07%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$1024.09 - $1201.76 $17.8 Million - $20.9 Million	17,389 Added 6.83%	271,850 $286 Million
Q2 2024 Aug 13, 2024	SELL	$883.2 - $1071.19 $2.67 Million - $3.23 Million	-3,020 Reduced 1.17%	254,461 $267 Million
Q1 2024 May 13, 2024	BUY	$902.69 - $993.35 $111 Million - $122 Million	122,544 Added 90.82%	257,481 $248 Million
Q4 2023 Feb 09, 2024	BUY	$775.18 - $881.7 $23.7 Million - $26.9 Million	30,517 Added 29.23%	134,937 $119 Million
Q3 2023 Nov 09, 2023	SELL	$692.45 - $844.37 $38.8 Million - $47.3 Million	-56,022 Reduced 34.92%	104,420 $85.9 Million
Q2 2023 Aug 11, 2023	BUY	$700.03 - $830.35 $41 Million - $48.7 Million	58,598 Added 57.54%	160,442 $115 Million
Q1 2023 May 12, 2023	SELL	$680.49 - $826.97 $25.5 Million - $31 Million	-37,451 Reduced 26.89%	101,844 $83.7 Million
Q4 2022 Feb 08, 2023	BUY	$705.89 - $766.39 $62.2 Million - $67.6 Million	88,154 Added 172.37%	139,295 $100 Million
Q3 2022 Nov 10, 2022	SELL	$573.97 - $724.32 $42 Million - $53 Million	-73,182 Reduced 58.86%	51,141 $35.2 Million
Q2 2022 Aug 10, 2022	BUY	$548.35 - $738.84 $10.4 Million - $14 Million	18,975 Added 18.01%	124,323 $73.5 Million
Q1 2022 May 16, 2022	SELL	$595.12 - $698.43 $49.9 Million - $58.5 Million	-83,823 Reduced 44.31%	105,348 $73.6 Million
Q4 2021 Feb 14, 2022	SELL	$543.48 - $670.97 $9.08 Million - $11.2 Million	-16,706 Reduced 8.11%	189,171 $119 Million
Q3 2021 Nov 15, 2021	BUY	$574.03 - $680.96 $27.6 Million - $32.8 Million	48,150 Added 30.53%	205,877 $125 Million
Q2 2021 Aug 13, 2021	SELL	$472.8 - $558.54 $359,328 - $424,490	-760 Reduced 0.48%	157,727 $88.1 Million
Q1 2021 May 12, 2021	BUY	$446.73 - $548.2 $8.45 Million - $10.4 Million	18,922 Added 13.56%	158,487 $75 Million
Q4 2020 Feb 11, 2021	BUY	$478.3 - $607.98 $27.7 Million - $35.3 Million	57,996 Added 71.1%	139,565 $67.4 Million
Q3 2020 Nov 12, 2020	SELL	$544.75 - $658.21 $24.7 Million - $29.8 Million	-45,315 Reduced 35.71%	81,569 $45.7 Million
Q2 2020 Jul 31, 2020	BUY	$493.32 - $643.92 $15.2 Million - $19.8 Million	30,814 Added 32.07%	126,884 $79.1 Million
Q1 2020 May 01, 2020	SELL	$336.18 - $494.43 $8.19 Million - $12.1 Million	-24,372 Reduced 20.24%	96,070 $46.9 Million
Q4 2019 Feb 14, 2020	SELL	$274.13 - $376.51 $5.67 Million - $7.78 Million	-20,670 Reduced 14.65%	120,442 $45.2 Million
Q3 2019 Nov 14, 2019	BUY	$273.46 - $318.39 $9.21 Million - $10.7 Million	33,692 Added 31.36%	141,112 $39.1 Million
Q2 2019 Aug 14, 2019	SELL	$299.6 - $414.82 $19.6 Million - $27.2 Million	-65,499 Reduced 37.88%	107,420 $33.6 Million
Q1 2019 May 14, 2019	BUY	$372.08 - $439.57 $25.1 Million - $29.7 Million	67,585 Added 64.16%	172,919 $71 Million
Q4 2018 Feb 14, 2019	SELL	$335.82 - $403.04 $5.45 Million - $6.54 Million	-16,215 Reduced 13.34%	105,334 $39.3 Million
Q3 2018 Nov 14, 2018	BUY	$351.14 - $408.51 $8.08 Million - $9.4 Million	23,021 Added 23.36%	121,549 $49.1 Million
Q2 2018 Aug 14, 2018	BUY	$284.6 - $344.99 $3.52 Million - $4.27 Million	12,366 Added 14.35%	98,528 $34 Million
Q1 2018 May 15, 2018	SELL	$315.82 - $393.78 $16 Million - $19.9 Million	-50,582 Reduced 36.99%	86,162 $29.7 Million
Q4 2017 Feb 14, 2018	BUY	$358.63 - $469.95 $15.7 Million - $20.6 Million	43,872 Added 47.24%	136,744 $51.4 Million
Q3 2017 Nov 14, 2017	BUY	$431.38 - $504.0 $12.9 Million - $15.1 Million	29,959 Added 47.62%	92,872 $41.5 Million
Q2 2017 Aug 14, 2017	BUY	N/A	7,454 Added 13.44%	62,913 $30.9 Million
Q1 2017 Nov 14, 2017	BUY	N/A	55,459	55,459 $21.5 Million

Others Institutions Holding REGN

# of Institutions

1,535

Shares Held

83.8M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $79.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account